Citations(0)

Content

How to Cite This Article

Download Download [ PDF ]

Email Send to a friend

Page Views Page Views(263)

Facebook ShareFacebook Share

Twitter ShareTwitter Share

Year : 2020 Month : September Volume : 9 Issue : 39 Page : 2913-2918

The Pandemic of 21st Century - COVID-19

Lata Kanyal Butola1, Ranjit Ambad2, Prakash Keshaorao Kute3, Roshan Kumar Jha4, Amol Dattaroa Shinde5

1 Department of Biochemistry, JNMC Sawangi, DMIMS, Wardha, Maharashtra, India.
2 Department of Biochemistry, JNMC Sawangi, DMIMS, Wardha, Maharashtra, India.
3 Department of Biochemistry, JNMC Sawangi, DMIMS, Wardha, Maharashtra, India.
4 Department of Biochemistry, JNMC Sawangi, DMIMS, Wardha, Maharashtra, India.
5 Department of Biochemistry, JNMC Sawangi, DMIMS, Wardha, Maharashtra, India.

CORRESPONDING AUTHOR

Lata Kanyal Butola, Tutor, Department of Biochemistry, JNMC Sawangi, DMIMS, Wardha, Maharashtra, India.
Email : kanyallata1010@gmail.com

ABSTRACT

BACKGROUND

The global pandemic of novel coronavirus disease is mainly caused by the infection of Coronavirus ‘SARS-CoV-2’. It is infecting persons of all ethnicity, race and community. Corona viruses are enveloped RNA viruses which range from 60 to 140 nm in diameter with spike like projections on their top. Coronavirus is affecting 199 countries, territories and international transport systems. Covid-19 is a recent pandemic, which started in Wuhan, China, at the end of 2019 and now it is affecting the whole world. WHO declared this outbreak as a pandemic on March 11, 2020. COVID-19 infection is transmitted by inhalation or contact with infected droplets or aerosols of infected persons, and the incubation period ranges from 5 to 14 days. Viral aerosols remain active for 3 hours in the air, 24 hours on cardboards, and 2 to 3 days on stainless steel and plastic. Symptoms are usually fever, cough, breathlessness, sore throat, malaise and fatigue. In some people, it may progress to pneumonia, multiple organ dysfunction, and acute respiratory distress syndrome. People with heart diseases, lung diseases, cancer, old age, diabetics, Immunosuppressed, and pregnant women are at higher risk for COVID-19 infection. To date, there are now more than 2,732,701 cases of COVID 19 globally with more than 191,150 deaths. In India, total cases are 23,502 with 722 deaths. First case of coronavirus was seen on 29 January 2020. On 24 March 2020, the government of India under Prime Minister Shri Narendra Modi ordered a nationwide lockdown for 21 days, after a 14-hour voluntary public curfew on 22nd March. India is one of the most populous countries of the world. India has the second largest population in the world. Due to the lack of vaccines, ventilators, targeted therapies, mass gatherings, the Indian government started lockdown, the largest exercise in the world with the second largest population. To reduce public movement, section 144 was implemented in many states. A full lockdown will help the collapse of the whole national health system.

 

KEY WORDS

Corona Virus, Pandemic, SARS, Transmission, Pandemic

BACKGROUND

Coronaviruses are pathogenic agents that cause serious diseases in a variety of animal species including infections in humans. The virus causes illnesses such as common cold, severe acute respiratory syndrome and middle east respiratory syndrome, but then it started showing a cluster of different diseases[1], by the end of 2002. Coronavirus leads to the development of “Severe Acute Respiratory Syndrome (SARS-CoV)” which emerged in China by the end of 2019 and it spread rapidly all over the world, resulting in around 8,000 deaths in 10 percent of the population. [2-4] In Saudi Arabia, the “Middle East Respiratory Disease Coronavirus (MERS-CoV)” arose in 2012 as a novel coronavirus that infected humans and had spread to nine additional countries.[5,6] 182 “MERS-CoV” cases have been reported till date, resulting in 79 fatalities.

Medical presentation of infected patients have shown acute pneumonia, frequently involving kidney diseases.[7] CoVs are similar to the SARS-CoV and MERS-CoV which were mainly isolated from the bats and spread worldwide,[8-9]providing a possible reservoir  for novice outbreaks of novel zoonoses into humans. There are total 6 species of Coronavirus, from which 1 species is divided into 2 strains making up 7 human coronavirus strains. Four of these, that mainly produce mild symptoms are, “Human Coronavirus OC43”, “Human Coronavirus HKU1”, “Human coronavirus 229E”, “Human Coronavirus NL63”. Three human coronaviruses primarily cause extreme symptoms, Middle East Respiratory Syndrome-Related Coronavirus (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV) and Severe Acute Respiratory Syndrome 2 (SARS-CoV-2). The COVID-19 causing pathogen were first identified in late January 2020, called SARS-CoV-2 and it is also known as 2019-nCoV,[10,11] a novel virus not previously experienced in humans; coronavirus has caused a global outbreak which has triggered the World Health Organization (WHO) to declare an emergency of international concern for public health.[12] COVID-19 is a zoonotic disease that is introduced into the human population by bats.[13-14] The SARS-CoV-2, a transitional animal host between a plausible bat reservoir and humans is still unknown.[15] The first array of cases detected at the end of 2019 were linked to marked seafood in Wuhan, China.[13]

The first imported case of COVID-19 was registered in Thailand on 13 January. A second case imported into Japan was found two days later. South Korea was the third country to report an Imported COVID-19 case.[16] Coronaviruses are a highly diverse group of enveloped, single-stranded, positive sense RNA viruses,[17] causing various diseases affecting respiratory system, enteric, hepatic  and neurological systems with varying severity among humans and animals.[17,18] Corona viruses have envelope spike protein which is very necessary for its morphology.[19] The S protein promotes the binding of receptors and helps in membrane fusion, and it is essential to confirm host tropism and transmission capacity.[20-22] In general, the S protein is divided functionally into 2 domains mainly the receptor-binding domain S1, and the S2 domain, which is responsible for the cell membrane fusion.[23] Further the analysis of structure has shown that the receptor-binding domain consisted of a core and an external sub domain. The enzyme-converting angiotensin II was known as the SARS-CoV cell receptor.[24-26] In the biophysical and the structural research, it is suggested that the SARS-CoV-2 gets bound to ACE2 with approximately 10- to 20-fold higher affinity than the SARS-CoV protein.[27] The high affinity of S protein to human ACE2 can facilitate SARS-CoV-2 spread among the human population. While, SARS-CoV-2 doesn’t use the other coronavirus receptors for entering cells, such as aminopeptidase N and Dipeptidyl peptidase 4.Common clinical results in the laboratory cover leucopenia and lymphopenia. The main fascinating feature of COVID-19 is lymphopenia, and the levels of Lactate dehydrogenase are elevated with an increase in creatinine kinase. Half of the patients are having elevated alanine aminotransferase or aspartate aminotransferase (SGOT,SGPT) that have impaired liver function. Most of the patients had shown abnormal myocardial zymogram that also shows increase levels of creatine kinase and lactate dehydrogenase. Many of the patients displayed normal procalcitonin serum levels but the c-reactive protein was above normal range, one third of patients had increased D-dimer.[28-31] On study analysis, the changes for serum cytokines in COVID-19 patients which indicates triggering of immune response, would lead in the development of chemokines and cytokines and at the end it harms normal host lung.[31]

Protective measures suggested by the world health organization in relation to Covid-19 awareness and information through media include:

  1. Hands should be washed frequently with an alcohol based hand rub or soap.
  2. Maintain a distance of at least 1 meter from the person coughing or sneezing.
  3. Prevent rubbing of the head, nose and mouth by dirty hands.
  4. Exercise respiratory hygiene by covering the mouth and nose with a bent elbow while coughing or sneezeing and use masks or tissue.
  5. Early medical attention should be taken when fever, cough, and breathing problems are present.
  6. Minimal traffic in busy areas such as piligrmage sites, gardens, markets and tourist sites.
  7. Closure of nurseries, companies, local and foreign travel, schools and colleges, etc.
  8. If you have a fever, cough and breathing difficulty, seek medical attention.[32]

THE VIRION

Corona viruses are infectious pathogenic enveloped viruses between 80 and 120 nm in diameter, round or sometimes pleiomorphic virions, recording the largest genome (about 30 kb) of RNA till date.[33,34] The RNA genome is functionalized to construct a helical capsid with the base nucleocapside (N) protein located inside the viral membrane. Both of these coronavirus membranes consist of minimum 3 viral proteins, all were spike protein (S), the type 1 glycoprotein that builds the peplomers on the viron surface, by giving the virus its corona or crown-like morphology in electron microscope, the membrane protein or M protein, that intersects the membrane three times and also has a short N-terminal ectodomain and even having a cytoplasmic tail and a highly hydrophobic protein, small membrane protein (E).[35] The protein IBV E is composed of a short ectodomain, a transmembrane domain and a cytoplasmic tail.[36] MHV’s E protein is stated to stretch out the membrane twice, so both N and C termini are within the virion.[37] Some coronaviruses in group II have an extra membrane protein called hemagglutinin esterase (HE).[38]

Coronavirus is a large, approximately spherical particle with bulbous surface projection.[39] The viral envelope is mainly consisted of lipid bilayer in which the structural proteins Membrane (M), Envelope (E) and Spike (S) are intercalate[40] and the ratio of E:S:M in lipid bilayer is approximately 1:20:300[41] coronavirus has approximately 74 surface spikes.[42] The surface spikes of coronavirus are homotrimeric to S. protein and consist of S1 and S2 subunits. S1 protein is indeed a class I fusion protein that helps in receptor binding and membrane fusion between the host cell and the virus and the S1 subunit forms the spike 's head and has a receptor-binding domain, while the S2 subunit forms the spike’s stem and allows protease activation to be fused and the E and M proteins are critical in viral envelope formation and help to maintain shape and structure.[43] Within the envelope, Nucleoprotein is present that gets bound to the positive-sense single stranded RNA genome in beads on a string like conformation.[44] The ssRNA genome varies from 26.4 to 31.7 kilobases, which is the largest among all the RNA viruses and the genome has 5’Methylated cap and 3’polyadenylated tail.[43]

 

 

Transmission

The first step of viral infection is binding of receptor expressed by the host cells leading to the cell membrane by fusion. It is suspected that the primary or main target of the virus is the lung epithelial cells. Therefore, it was seen that human to human transmissions of SARS-CoV occur by linking the receptor-binding domain of virus spikes with the identified cellular receptor Known as the angiotensin- converting enzyme 2 receptor. Importantly, the COVID-19 sequences spike the receptor-binding domain parallel to the one of SARS-CoV. This evidence indicates strongly that the viruses most likely enter into the host cells via ACE2 receptors.[44-46]

The incubation period ranges from 1 to 12.5 days, but can be as long as 14 days. The signs between the preceding beta coronavirus and COVID-19 are generally similar. COVID-19, however, displayed some unusual clinical features including targeting the lower airways as evident from symptoms of the upper respiratory tract such as rhinorrhoea, sneezing and sore throats. In addition, only a small percentage of MERS-CoV or SARS-CoV shows intestinal symptoms such as diarrhoeain patients diagnosed with COVID-19.

Bats seem to be the source of a wide variety of coronaviruses including “Severe Acute Coronavirus Respiratory Syndrome (SARS-CoV)” like viruses. SARS-CoV -2 may emerge from bats or unknown intermediate hosts, and may cross human boundaries of the species. Interactions with host-viruses affect the input and replication of viruses. SARS-CoV-2 is a two-thirds enveloped single stranded positive RNA (ssRNA), predominantly located within the first open reading frame (ORF 1A/B), which codes 16 non-structural proteins (NSPs). The remaining of the genome codes for viruses are four basic structural proteins, including spike, envelope, matrix and nucleocapsid (N) protein, and several accessory proteins. SARS-CoV-2 glycoprotein binds 2 (ACE2) angiotensin-converting enzyme to host cell receptors, a crucial step in virus entry. Many virus-bearing proteins may contribute to pathogenesis. Infection tolerance and disease progression can also be affected by host factors.

THE VIRION


Figure 1. Systemic and Respiratory Problems Caused by COVID-19 Infection

 

After receptor interactions and the fusion of viral and plasma membrane, the virus-specific RNA and Proteins are synthesized, perhaps entirely within the cytoplasm. Coronaviral activation begins with the translation into the proteins that make up the replicase complex of two polyproteins, pp1a and pp1ab, that undergo cotranslational proteolytic processing. The entire complex is used for transcribing a3-coterminal series of recursive subgenomic mRNAs as well as genomic RNA, which has a common 5-leader series obtained from the 5-end genome. Proteins are translated at the 5-end of a mRNA. New viruses are brought together by budding through intracellular membrane and emitted by vesicles through the cell secretory mechanism. The principal protein of replicase-transcriptase is polymerase RNA-dependent.[47]

 

Figure 2. Viral and Host Factors, Affecting SARS-CoV-2 Pathogenesis

 

 

Figure 3. Replication Model of Coronavirus

CONCLUSIONS

People need to be aware of the severity of COVID-19 and take measures to ensure themselves, such as remaining at home, limiting social contacts, avoiding public gatherings, maintaining distance, and wearing appropriate masks in public. The authorities should encourage peoples to stay at home; should stop mass gathering; should postpone or cancel public activities and should close public institutions. Such preventive steps will help the countries infected with COVID-19 Pandemic. We conclude masks alone do not protect against COVID-19, it should be combined with physical distancing, hand hygiene and follow the advice provided by your local health authority.

REFERENCES

1

Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 2009;7(6):439-50.     

CrossRef | Google Scholar | PubMed
2

Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300(5624):1394-9. 

CrossRef | Google Scholar | PubMed
3

Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1967-76.

CrossRef | Google Scholar | PubMed
4

Pyrc K, Berkhout B, van der Hoek L. The novel human coronaviruses NL63 and HKU1. J Virol 2007;81(7):3051-7.    

CrossRef | Google Scholar | PubMed
5

Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367(19):1814-20.      

CrossRef | Google Scholar | PubMed
6

Danielsson N, Catchpole M. Novel coronavirus associated with severe respiratory disease: case definition and public health measures. Euro Surveill 2012;17(39):20282.                           

CrossRef | Google Scholar | PubMed
7

Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013;369(5):407-16.    

CrossRef | Google Scholar | PubMed
8

Muller MA, Paweska JT, Leman PA, et al. Coronavirus antibodies in African bat species. Emerg Infect Dis 2007;13(9):1367-70.  

CrossRef | Google Scholar | PubMed
9

Chu DKW, Peiris JSM, Chen H, et al. Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats. J Gen Virol 2008;89(Pt 5):1282-7.                            

CrossRef | Google Scholar | PubMed
10

Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395(10224):565-574.                          

CrossRef | Google Scholar | PubMed
11

Zhu N, Zhang D, Wang W, et al. A Novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727-33.     

CrossRef | Google Scholar | PubMed
12

                World Health Organisation. Novel Coronavirus (2019nCoV) Situation Report - 11, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200131-sitrep-11-ncov.pdf?sfvrsn=de7c0f7_4       

CrossRef |
13

Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579(7798):270-3.  

CrossRef | Google Scholar | PubMed
14

Zhou P, Yang XL, Wang XG, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. BioRxiv 2020. DOI:

CrossRef | PubMed
15

Li X, Zai J, Zhao Q, et al. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. J Med Virol 2020;92(6):602-11.   

CrossRef | Google Scholar | PubMed
16

World Health Organisation. Novel coronavirus (2019-nCoV) Situation Report - 1, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4      

CrossRef |
17

Zumla A, Chan JFW, Azhar EI, et al. Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov 2016;15(5):327-47.     

CrossRef | Google Scholar | PubMed
18

Chan JFW, Lau SKP, Woo PCY. The emerging novel Middle East respiratory syndrome coronavirus: the "knowns" and "unknowns". J Formos Med Assoc 2013;112(7):372-81.                        

CrossRef | Google Scholar | PubMed
19

Du L, He Y, Zhou Y, et al. The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol 2009;7(3):226-36.  

CrossRef | Google Scholar | PubMed
20

Wang Q, Wong G, Lu G, et al. MERS-CoV spike protein: targets for vaccines and therapeutics. Antiviral Res 2016;133:165-77.         

CrossRef | Google Scholar | PubMed
21

Lu G, Wang Q, Gao GF. Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol 2015;23(8):468-78.

CrossRef | Google Scholar | PubMed
22

Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 2016;3(1):237-61.                 

CrossRef | Google Scholar | PubMed
23

He Y, Zhou Y, Liu S, et al. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun 2004;324(2):773-81.              

CrossRef | Google Scholar | PubMed
24

Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest 2009;39(7):618-25.

CrossRef | Google Scholar | PubMed
25

Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426(6965):450-4.       

CrossRef | Google Scholar | PubMed
26

Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005;11(8):875-9.  

CrossRef | Google Scholar | PubMed
27

Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;367(6483):1260-3.

CrossRef | Google Scholar | PubMed
28

Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199-207.        

CrossRef | Google Scholar | PubMed
29

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061-9.               

CrossRef | Google Scholar | PubMed
30

Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223):507-13.                 

CrossRef | Google Scholar | PubMed
31

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.              

CrossRef | Google Scholar | PubMed
32

World Health Organisation. Coronavirus. WHO 2020.

CrossRef |
33

Lee HJ, Shieh CK, Gorbalenya AE, et al. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology 1991;180(2):567-82.                          

CrossRef | Google Scholar | PubMed
34

Lomniczi BJ. Biological properties of avian coronavirus RNA. J Gen Virol 1977;36(3):531-3.                              

CrossRef | Google Scholar | PubMed
35

Bond CW, Leibowitz JL, Robb JA. Pathogenic murine coronaviruses. II. Characterization of virus-specific proteins of murine coronaviruses JHMV and A59V. Virology 1979;94(2):371-84.                                  

CrossRef | Google Scholar | PubMed
36

Corse E, Machamer CE. Infectious bronchitis virus E protein is targeted to the golgi complex and directs release of virus-like particles. J Virol 2000;74(9):4319-26. 

CrossRef | Google Scholar | PubMed
37

Maeda J, Repass JF, Maeda A, et al. Membrane topology of coronavirus E protein. Virology 2001;281(2):163-9.          

CrossRef | Google Scholar | PubMed
38

Brian DA, Hogue BG, Kienzle TE. The coronavirus hemagglutinin esterase glycoprotein. In: Siddell SG, ed. The coronaviridae. New York: Plenum Press 1995:165-79.

39

Wan Y, Shang J, Graham R, et al. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020;94(7):e00127-20.               

CrossRef | Google Scholar | PubMed
40

Goldsmith CS, Tatti KM, Ksiazek TG, et al. Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis 2004;10(2):320-6.         

CrossRef | Google Scholar | PubMed
41

Lai MMC, Cavanagh D. The molecular biology of coronaviruses. Advances in Virus Research Vol. 48. Academic Press 1997:1-100.        

42

Chen YN. Identification and Characterization of Neutralizing Epitopes on Spike Protein of Turkey Coronavirus. Purdue University, ProQuest Dissertations Publishing 2010.           

Google Scholar |
43

Neuman BW, Kiss G, Kunding AH, et al. A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol 2011;174(1):11-22.  

CrossRef | Google Scholar | PubMed
44

Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In: Maier HJ, Bickerton E, Britton P, eds. Coronaviruses: methods and protocols. New York: Humana Press 2015:1-23.

45

Wu P, Hao X, Lau EHY, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill 2020;25(3):2000044.                     

CrossRef | Google Scholar | PubMed
46

Jaimes JA, Millet JK, Stout AE, et al. A tale of two viruses: the distinct spike glycoproteins of feline coronaviruses. Viruses 2020;12(1):83.

CrossRef | Google Scholar | PubMed
47

Sexton NR, Smith EC, Blanc H, Vignuzzi M, et al. Homology-based identification of a mutation in the coronavirus RNA-dependent RNA polymerase that confers resistance to multiple mutagens. J Virol 2016;90(16):7415-28.          

CrossRef | Google Scholar | PubMed

How to cite this article

Butola LK, Ambad R, Kute PK, et al. The pandemic of 21st century- COVID-19. J. Evolution Med. Dent. Sci. 2020;9(39): 2913-2918, DOI: 10.14260/jemds/2020/637

Videos :

watch?v